Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112


Prognostic relevance of ubiquitin C-terminal hydrolase L1 (UCH-L1) mRNA and protein expression in breast cancer patients.

Schröder C, Milde-Langosch K, Gebauer F, Schmid K, Mueller V, Wirtz RM, Meyer-Schwesinger C, Schlüter H, Sauter G, Schumacher U.

J Cancer Res Clin Oncol. 2013 Oct;139(10):1745-55. doi: 10.1007/s00432-013-1496-z. Epub 2013 Aug 31.


UCH-L1 involved in regulating the degradation of EGFR and promoting malignant properties in drug-resistant breast cancer.

Jin Y, Zhang W, Xu J, Wang H, Zhang Z, Chu C, Liu X, Zou Q.

Int J Clin Exp Pathol. 2015 Oct 1;8(10):12500-8. eCollection 2015.


Potential prognostic marker ubiquitin carboxyl-terminal hydrolase-L1 does not predict patient survival in non-small cell lung carcinoma.

Orr KS, Shi Z, Brown WM, O'Hagan KA, Lappin TR, Maxwell P, Percy MJ.

J Exp Clin Cancer Res. 2011 Aug 30;30:79. doi: 10.1186/1756-9966-30-79.


High expression of ubiquitin carboxy-terminal hydrolase-L1 and -L3 mRNA predicts early recurrence in patients with invasive breast cancer.

Miyoshi Y, Nakayama S, Torikoshi Y, Tanaka S, Ishihara H, Taguchi T, Tamaki Y, Noguchi S.

Cancer Sci. 2006 Jun;97(6):523-9.


UCH-LI acts as a novel prognostic biomarker in gastric cardiac adenocarcinoma.

Yang H, Zhang C, Fang S, Ou R, Li W, Xu Y.

Int J Clin Exp Pathol. 2015 Nov 1;8(11):13957-67. eCollection 2015.


Overexpression of ubiquitin carboxyl terminal hydrolase-L1 enhances multidrug resistance and invasion/metastasis in breast cancer by activating the MAPK/Erk signaling pathway.

Wang W, Zou L, Zhou D, Zhou Z, Tang F, Xu Z, Liu X.

Mol Carcinog. 2016 Sep;55(9):1329-42. doi: 10.1002/mc.22376. Epub 2015 Aug 21.


Over-expression of ubiquitin carboxy terminal hydrolase-L1 induces apoptosis in breast cancer cells.

Wang WJ, Li QQ, Xu JD, Cao XX, Li HX, Tang F, Chen Q, Yang JM, Xu ZD, Liu XP.

Int J Oncol. 2008 Nov;33(5):1037-45.


UCH-L1-containing exosomes mediate chemotherapeutic resistance transfer in breast cancer.

Ning K, Wang T, Sun X, Zhang P, Chen Y, Jin J, Hua D.

J Surg Oncol. 2017 Jun;115(8):932-940. doi: 10.1002/jso.24614. Epub 2017 Mar 23.


Histone demethylase GASC1--a potential prognostic and predictive marker in invasive breast cancer.

Berdel B, Nieminen K, Soini Y, Tengström M, Malinen M, Kosma VM, Palvimo JJ, Mannermaa A.

BMC Cancer. 2012 Nov 14;12:516. doi: 10.1186/1471-2407-12-516.


Differential expression of ubiquitin carboxy-terminal hydrolase L1 in breast carcinoma and its biological significance.

Lien HC, Wang CC, Lin CH, Lu YS, Huang CS, Hsiao LP, Yao YT.

Hum Pathol. 2013 Sep;44(9):1838-48. doi: 10.1016/j.humpath.2013.02.006. Epub 2013 May 7.


Ubiquitin C-terminal hydrolase-L1 increases cancer cell invasion by modulating hydrogen peroxide generated via NADPH oxidase 4.

Kim HJ, Magesh V, Lee JJ, Kim S, Knaus UG, Lee KJ.

Oncotarget. 2015 Jun 30;6(18):16287-303.


Ubiquitin C-terminal hydrolase-L1 (Uch-L1) correlates with gonadal transformation in the rice field eel.

Sun J, Shang X, Tian Y, Zhao W, He Y, Chen K, Cheng H, Zhou R.

FEBS J. 2008 Jan;275(2):242-9. Epub 2007 Dec 11. Erratum in: FEBS J. 2008 Feb;275(4):812.


Ubiquitin C-terminal hydrolase L1 (UCH-L1): structure, distribution and roles in brain function and dysfunction.

Bishop P, Rocca D, Henley JM.

Biochem J. 2016 Aug 15;473(16):2453-62. doi: 10.1042/BCJ20160082. Review.


The regulation of the UCH-L1 gene by transcription factor NF-κB in podocytes.

Zhang H, Sun Y, Hu R, Luo W, Mao X, Zhao Z, Chen Q, Zhang Z.

Cell Signal. 2013 Jul;25(7):1574-85. doi: 10.1016/j.cellsig.2013.03.018. Epub 2013 Apr 6. Erratum in: Cell Signal. 2014 Feb;26(2):460.


Cloning and expression analysis of a Parkinson's disease gene, uch-L1, and its promoter in zebrafish.

Son OL, Kim HT, Ji MH, Yoo KW, Rhee M, Kim CH.

Biochem Biophys Res Commun. 2003 Dec 19;312(3):601-7.


High levels of γ-glutamyl hydrolase (GGH) are associated with poor prognosis and unfavorable clinical outcomes in invasive breast cancer.

Shubbar E, Helou K, Kovács A, Nemes S, Hajizadeh S, Enerbäck C, Einbeigi Z.

BMC Cancer. 2013 Feb 1;13:47. doi: 10.1186/1471-2407-13-47.


β-Amyloid (Aβ) oligomers impair brain-derived neurotrophic factor retrograde trafficking by down-regulating ubiquitin C-terminal hydrolase, UCH-L1.

Poon WW, Carlos AJ, Aguilar BL, Berchtold NC, Kawano CK, Zograbyan V, Yaopruke T, Shelanski M, Cotman CW.

J Biol Chem. 2013 Jun 7;288(23):16937-48. doi: 10.1074/jbc.M113.463711. Epub 2013 Apr 18.


Parkin-mediated K63-polyubiquitination targets ubiquitin C-terminal hydrolase L1 for degradation by the autophagy-lysosome system.

McKeon JE, Sha D, Li L, Chin LS.

Cell Mol Life Sci. 2015 May;72(9):1811-24. doi: 10.1007/s00018-014-1781-2. Epub 2014 Nov 18.


Ubiquitin C-Terminal Hydrolase L1 (UCH-L1) Promotes Hippocampus-Dependent Memory via Its Deubiquitinating Effect on TrkB.

Guo YY, Lu Y, Zheng Y, Chen XR, Dong JL, Yuan RR, Huang SH, Yu H, Wang Y, Chen ZY, Su B.

J Neurosci. 2017 Jun 21;37(25):5978-5995. doi: 10.1523/JNEUROSCI.3148-16.2017. Epub 2017 May 12.


Ubiquitin C-terminal hydrolase L1 (UCH-L1) acts as a novel potentiator of cyclin-dependent kinases to enhance cell proliferation independently of its hydrolase activity.

Kabuta T, Mitsui T, Takahashi M, Fujiwara Y, Kabuta C, Konya C, Tsuchiya Y, Hatanaka Y, Uchida K, Hohjoh H, Wada K.

J Biol Chem. 2013 May 3;288(18):12615-26. doi: 10.1074/jbc.M112.435701. Epub 2013 Mar 29.

Supplemental Content

Support Center